alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| (logo) WELLS

           FARGO | **Commercial  Mortgage Servicing**D1050-084,  8th Floor  401 South Tryon St.  Charlotte, NC 28202  1-800-326-1334

 

  |
|----------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|

**ANNUAL STATEMENT OFCOMPLIANCE**

** **

** **

Reference is herebymade to that certain Pooling and Servicing Agreement dated as of May 1, 2015,by and among CREDIT SUISSE FIRST BOSTON MORTGAGE SECURITIES CORP., asDepositor, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Master Servicer, RIALTOCAPITAL ADVISORS, LLC, as Special Servicer, PARK BRIDGE LENDER SERVICES LLC, asOperating Advisor, WELLS FARGO BANK, NATIONAL ASSOCIATION, as CertificateAdminstrator, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee, withrespect to Commercial Mortgage Pass-Through Certificates, Series 2015-C2 (the"Agreement"). Capitalized terms used herein not otherwise definedshall have the meanings assigned in the Agreement.

 

Pursuant to Section10.07 of this Agreement, I, Leslie Hayton, Managing Director of CommercialMortgage Services do hereby certify that:

 

1.           Areview of the activities of the Master Servicer during the period from January1, 2018 through December 31, 2018 (the “Reporting Period”), and of itsperformance per the Agreement during such period has been made under mysupervision, and

 

2.           To thebest of my knowledge, based on such review, the Master Servicer, has fulfilledall of its obligations under this Agreement in all material respects throughoutthe Reporting Period.

 

 

IN WITNESS WHEREOF,the undersigned has executed this Certificate as of the 28th day ofFebruary 2019.

 

 

/s/Leslie Hayton

Leslie Hayton 

Managing Director

Wells Fargo Bank

 

 

| Wells Fargo Bank,  N.A. | (logo) Together  we’ll go far |
|-------------------------|-------------------------------------|
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.5925 Traction accessory. ( a ) *Identification.* A traction accessory is a nonpowered accessory device intended for medical purposes to be used with powered traction equipment to aid in exerting therapeutic pulling forces on the patient's body. This generic type of device includes the pulley, strap, head halter, and pelvic belt.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 890.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, regarding general requirements concerning records and § 820.198, regarding complaint files.
[48 FR 53047, Nov. 23, 1983, as amended at 61 FR 1125, Jan. 16, 1996; 66 FR 38818, July 25, 2001]
Fourth Court of Appeals

San Antonio, Texas

February 13, 2023

No. 04-22-00440-CR

Correy REYES-BROWN,

Appellant

v.

The STATE of Texas,

Appellee

From the 25th Judicial District Court, Guadalupe County, Texas

Trial Court No. 20-1498-CR-C

Honorable William D. Old III, Judge Presiding

O R D E R

Appellant’s brief was originally due December 7, 2022. Appellant’s first motion 

requesting an extension of time to file the brief was granted, extending the deadline for filing the 

brief to February 6, 2023. Neither the brief nor a motion for extension of time to file the brief has 

been filed. 

We therefore ORDER appellant’s attorney to file his brief by February 23, 2023, If 

neither the brief nor an extension of time to file the brief is filed by the date ordered, we will 

order the appeal abated and remand the cause to the trial court for a hearing to determine whether 

appellant or appointed counsel has abandoned the appeal. See TEX. R. APP. P. 38.8(b)(2). 

_________________________________

Beth Watkins, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 13th day of February, 2023.

___________________________________

MICHAEL A. CRUZ, Clerk of Court
Executive Order 12866:

Could the AD be considered a “significant regulatory action”?

YES* NO 

*Explanation: 

DOT Regulatory Policies and Procedures:

Is the AD significant? 

YES* NO 

*Explanation: 

Regulatory Flexibility Act:

Will the AD have a significant economic impact on a substantial number of small entities? Explain for 

either a Yes or No answer.

YES NO 

Explanation: 

Intrastate Aviation in Alaska:

This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific requirements for 

aircraft operated in Alaska where aviation might be the only mode of transportation?

YES* NO 

*Explanation:
Section 302 Certification of Chief Financial and Administrative Officer



 
 
EXHIBIT 10.3 
 
SECTION 302 CERTIFICATION OF CHIEF FINANCIAL AND ADMINISTRATIVE OFFICER 
 
I, Patricio E. de la Garza, certify that: 
 
1.  I have reviewed this annual report on Form 20-F of Alestra, S. de R.L. de C.V.; 
 
2.  Based on my knowledge, this annual report does
not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this annual report; 
 
3. Based on my knowledge,
the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this annual report; 
 
4.  The
registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: 
 

	 	a.	 	designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this annual report is being prepared; 

 

	 	b.	 	evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report
(the “Evaluation Date”); and 

 

	 	c.	 	presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;


 
5.  The
registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

	 	a.	 	all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize
and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and 

 

	 	b.	 	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and


 
6.  The
registrant’s other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of
our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. 
 
 
Date: March 31, 2003 
 

	 /S/    PATRICIO E. DE
LA GARZA

 Patricio E. de la
Garza
 Chief Financial and Administrative Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS 

FOR THE FOURTH CIRCUIT 

No. 09-6660

CHARLES JERALL SMITH, 

 Petitioner - Appellant, 

 v. 

GENE M. JOHNSON, 

 Respondent - Appellee. 

Appeal from the United States District Court for the Eastern 

District of Virginia, at Richmond. M. Hannah Lauck, Magistrate 

Judge. (3:05-cv-00196-MHL) 

Submitted: August 21, 2009 Decided: September 11, 2009 

Before MOTZ, KING, and SHEDD, Circuit Judges. 

Dismissed by unpublished per curiam opinion. 

Charles Jerall Smith, Appellant Pro Se. Karen Geneva Misbach, 

OFFICE OF THE ATTORNEY GENERAL OF VIRGINIA, Richmond, Virginia, 

for Appellee.

Unpublished opinions are not binding precedent in this circuit. 
PER CURIAM: 

Charles Jerall Smith seeks to appeal the magistrate 

judge’s order treating his Fed. R. Civ. P. 60(b) motion as a 

successive 28 U.S.C. § 2254 (2006) petition, and dismissing it 

on that basis.* The order is not appealable unless a circuit 

justice or judge issues a certificate of appealability. 28 

U.S.C. § 2253(c)(1) (2006); Reid v. Angelone, 369 F.3d 363, 369 

(4th Cir. 2004). A certificate of appealability will not issue 

absent “a substantial showing of the denial of a constitutional 

right.” 28 U.S.C. § 2253(c)(2) (2006). A prisoner satisfies 

this standard by demonstrating that reasonable jurists would 

find the district court’s assessment of the constitutional 

claims, and any dispositive procedural ruling, debatable or 

wrong. Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003); 

Slack v. McDaniel, 529 U.S. 473, 484 (2000); Rose v. Lee, 252 

F.3d 676, 683-85 (4th Cir. 2001). We have independently 

reviewed the record and conclude Smith has not made the 

requisite showing. Accordingly, we deny a certificate of 

appealability and dismiss the appeal. 

Additionally, we construe Smith’s notice of appeal and 

informal brief as an application to file a second or successive 

 *

 The parties consented to have the case decided by a 

magistrate judge in accordance with 28 U.S.C. § 636(c) (2006). 

2 
3 

petition under 28 U.S.C. § 2244 (2006). United States v. 

Winestock, 340 F.3d 200, 208 (4th Cir. 2003). In order to 

obtain authorization to file a successive § 2254 petition, a 

prisoner must assert claims based on either: (1) a new rule of 

constitutional law that was previously unavailable and made 

retroactive by the Supreme Court to cases on collateral review; 

or (2) newly discovered evidence that was not previously 

discoverable by due diligence and that would be sufficient to 

establish by clear and convincing evidence that, but for 

constitutional error, no reasonable factfinder would have found 

the petitioner guilty of the offense. 28 U.S.C. § 2244(b)(2) 

(2006). Smith’s claims do not satisfy either of these criteria. 

Therefore, we deny authorization to file a successive § 2254 

petition. 

We dispense with oral argument because the facts and 

legal contentions are adequately presented in the materials 

before the court and argument would not aid the decisional 

process. 

DISMISSED
**EXHIBIT 31.1**

 

**CERTIFICATION**

 

I, Brett D. Davis, certify that:

 

1.                                      I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filed in respect of the period covered by this report on Form 10-K of CNH Equipment Trust 2015-C (the “Exchange Act periodic reports”);

 

2.                                      Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                      Based on my knowledge, all of the distribution, servicing and other information required to be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports;

 

4.                                      I am responsible for reviewing the activities performed by the servicer and based on my knowledge and the compliance review conducted in preparing the servicer compliance statement required in this report under Item 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicer has fulfilled its obligations under the servicing agreement in all material respects; and

 

5.                                      All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their related attestation reports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwise disclosed in this report. Any material instances of noncompliance described in such reports have been disclosed in this report on Form 10-K.

 

In giving the certifications above, I have reasonably relied on information provided to me by the following unaffiliated parties: Citibank, N.A.

 

March 25, 2019

 

 
|   | By:    | /s/ Brett D. Davis                                               |
|--------|--------|------------------------------------------------------------------|
|   | Name:  | Brett D. Davis                                                   |
|   | Title: | President (senior   officer in charge of the servicing function) |

 

----
<PAGE>

                                                                    EXHIBIT 31.1

                                  CERTIFICATION

I, Francis H. Murphy, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Biopure Corporation;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a- 15(e) and 15d-15(e)) for the registrant and
     have:

     (a) Designed such disclosure controls and procedures, or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure that material information relating to the registrant, including its
     consolidated subsidiaries, is made known to us by others within those
     entities, particularly during the period in which this report is being
     prepared;

     (b) Evaluated the effectiveness of the registrant's disclosure controls and
     procedures and presented in this report our conclusions about the
     effectiveness of the disclosure controls and procedures, as of the end of
     the period covered by this report based on such evaluation; and

     (c) Disclosed in this report any change in the registrant's internal
     control over financial reporting that occurred during the registrant's most
     recent fiscal quarter (the registrant's fourth fiscal quarter in the case
     of an annual report) that has materially affected, or is reasonably likely
     to materially affect, the registrant's internal control over financial
     reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors (or persons performing the equivalent functions):

     (a) All significant deficiencies and material weaknesses in the design or
     operation of internal control over financial reporting which are reasonably
     likely to adversely affect the registrant's ability to record, process,
     summarize and report financial information; and

     (b) Any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal control
     over financial reporting.

Date: March 15, 2004

/s/ Francis H, Murphy
---------------------
Francis H. Murphy
Chief Executive Officer
#### § 582.40 Natural extractives (solvent-free) used in conjunction with spices, seasonings, and flavorings.

Natural extractives (solvent-free) used in conjunction with spices, seasonings, and flavorings that are generally recognized as safe for their intended use, within the meaning of section 409 of the act, are as follows:

| Common name | Botanical name of plant source |
| --- | --- |
| Algae, brown | *Laminaria* spp. and *Nereocystis* spp. |
| Algae, red | *Porphyra* spp. and *Rhodymenia palmata* (L.) Grev. |
| Apricot kernel (persic oil) | *Prunus armeniaca* L. |
| Dulse | *Rhodymenia palmata* (L.) Grev. |
| Kelp (see algae, brown). | |
| Peach kernel (persic oil) | *Prunus persica* Sieb. et Zucc. |
| Peanut stearine | *Arachis hypogaea* L. |
| Persic oil (see apricot kernel and peach kernel). | |
| Quince seed | *Cydonia oblonga* Miller. |
<PAGE>   1

                                                                     EXHIBIT 5.1

                        [LETTERHEAD OF VENTURE LAW GROUP]

                               October 21, 1999

Corixa Corporation
1124 Columbia Street, Suite 200
Seattle, WA  98104

        REGISTRATION STATEMENT ON FORM S-8

Ladies and Gentlemen:

        We have examined the Registration Statement on Form S-8 (the
"Registration Statement") to be filed by Corixa Corporation ("Corixa") with the
Securities and Exchange Commission (the "Commission") in connection with the
registration under the Securities Act of 1933, as amended, of a total of 296,522
shares of Corixa's Common Stock (the "Shares") reserved for issuance by Corixa
pursuant to the Ribi Immunochem Research, Inc. 1986 Stock Option Plan, the Ribi
Immunochem Research, Inc. 1996 Director Option Plan and the Ribi Immunochem
Research, Inc. 1996 Stock Option Plan. As Corixa's legal counsel in connection
with this transaction, we have examined the proceedings taken and are familiar
with the proceedings proposed to be taken by Corixa in connection with the sale
and issuance of the Shares.

        It is our opinion that upon conclusion of the proceedings being taken or
contemplated by us, as Corixa's legal counsel, to be taken prior to the issuance
of the Shares, and upon completion of the proceedings being taken in order to
permit such transactions to be carried out in accordance with the securities
laws of the various states where required, the Shares when issued and sold in
the manner described in the Registration Statement will be legally and validly
issued, fully paid and non-assessable.

        We consent to the use of this opinion as an exhibit to the Registration
Statement and further consent to the use of our name wherever appearing in the
Registration Statement and in any amendment thereto.

        This opinion is solely for your benefit and may not be relied upon by
any other person without our prior written consent.

                                            Very truly yours,

                                            VENTURE LAW GROUP
                                            A Professional Corporation

                                            /s/Venture Law Group
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.1880 Fusion and stereoscopic target. ( a ) *Identification.* A fusion and stereoscopic target is a device intended for use as a viewing object with a stereoscope (§ 886.1870).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 886.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[52 FR 33355, Sept. 2, 1987, as amended at 53 FR 35606, Sept. 14, 1988; 66 FR 38813, July 25, 2001]
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 22
- 6481

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,

v. LAMONT TATE , Defendant

- Appellant

.

Appeal from the United States District Court for the Western District of North Carolina , at Charlotte

. Frank D. Whitney , District Judge. ( 3:01

- cr - 00185

- FDW

- 4 )

Submitted : January 20, 2023 Decided: February 6, 2023

Before THACKER and QUATTLEBAUM , Circuit Judges , and FLOYD, Senior Circuit Judge.

Affirmed by un published per curiam opinion

.

Lamont Tate , Appellant Pro Se.
Unpublished opinions are not binding precedent in this circuit. USCA4 Appeal: 22-6481 Doc: 10 Filed: 02/06/2023 Pg: 1 of 22 PER CURIAM:
Lamont Tate appeals the district court’s order denying his motion for reduction of sentence under the First Step Act of 2018, Pub. L. No. 115

- 391, 132 Stat. 5194

. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district cou rt. United States v. Tate , No. 3:01

- cr - 00185

- FDW

- 4 (W.D.N.C. Apr. 11, 2022) . We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional proc ess. AFFIRMED USCA4 Appeal: 22-6481 Doc: 10 Filed: 02/06/2023 Pg: 2 of 2
EXHIBIT 32.1
                                                                    ------------

                           SECTION 1350 CERTIFICATION


     I, Julie Smolyansky, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Quarterly Report of Lifeway Foods, Inc. (the "Company") on Form 10-QSB for three
month period ended September 30, 2005:

          (1) fully complies with the requirements of section 13(a) or 15(d) of
     the Securities Exchange Act of 1934; and

          (2) that the information contained in the report fairly presents, in
     all material respects, the financial condition and results of operations of
     the Company.

     This written statement is being furnished to the Securities and Exchange
Commission as an exhibit to such Form 10-QSB. A signed original of this written
statement required by Section 906 has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.


Date: November 15, 2005
                                      /s/ Julie Smolyansky
                                      ---------------------------------
                                      Julie Smolyansky, Chief Executive Officer,
                                      President, and Director